DABIGATRAN ETEXILATE MESYLATE | A207961 | HETERO LABS LTD UNIT III
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG et al v. HETERO USA, INC. et al 1 patentANDA 207961dabigatran etexilate mesylate | D.N.J. | 2016-04-26 | Terminated 2016-06-21 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.